Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique

References

• Ahmed Khames IIS, El Barry AA. (2006). Improvement of water miscibility of phytomenadione. The 30th International Conference of Pharmaceutical Society of Egypt. Egypt.
   Google Scholar
• Agency M.a.H.P.R. (2011). Available at: http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con123334.pdf [online]. [last accessed 30 Aug 2016].
   Google Scholar
• Armstrong RA, Slade S, Eperjesi F. (2000). An introduction to analysis of variance (ANOVA) with special reference to data from clinical experiments in optometry. Ophthalmic Physiol Opt 20:235–41.
   PubMed Web of Science ®Google Scholar
• Aziz HA, Tan YTF, Peh KK. (2012). Solubility of drugs in aqueous polymeric solution: effect of ovalbumin on microencapsulation process. AAPS PharmSciTech 13:35–45.
   PubMed Web of Science ®Google Scholar
• Badawy MA, Kamel AO, Sammour OA. (2016). Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study. Drug Deliv 23:808–17.
   PubMed Web of Science ®Google Scholar
• Bernal NP, Calpena AC, Mallandrich M, et al. (2014). Development, physical-chemical stability, and release studies of four alcohol-free spironolactone suspensions for use in pediatrics. Dissolut Technol 21:19–30.
   Web of Science ®Google Scholar
• Bladania S, Bhatt K, Mehta R, Shah D. (2008). RP-HPLC estimation of risperidone in tablet dosage forms. Ind J Pharm Sci 70:494
   PubMed Web of Science ®Google Scholar
• Boonleang J, Pipatrattanaseree W, Tanthana C, Mahatthanatrakul W. (2010). Relative bioavailability and pharmacokinetic comparison of two 2-mg risperidone tablet formulations: a single dose, randomized-sequence, double-blind, 2-way crossover study in healthy male volunteers in Thailand. Clin Ther 32:1842–53.
   PubMed Web of Science ®Google Scholar
• Burra S, Yamsani M, Vobalaboina V. (2011). The liquisolid technique: an overview. Brazilian J Pharm Sci 47:475–82.
   Web of Science ®Google Scholar
• Chella N, Narra N, Rama Rao T. (2014). Preparation and characterization of liquisolid compacts for improved dissolution of Telmisartan. J Drug Deliv 2014: Article ID 692793, 10 pages. doi:10.1155/2014/692793.
   PubMedGoogle Scholar
• Dai WG, Dong LC, Creasey AA. (2011). Inhibiting the precipitation of poorly water-soluble drugs from Labrasol formulations. Pharm Technol 35:50–4.
   Google Scholar
• Dixit M, Kini AG, Kulkarni PK. (2011). Enhancing the aqueous solubility and dissolution of olanzapine using freeze-drying. Brazilian J Pharm Sci 47:743–9.
   Web of Science ®Google Scholar
• Dixit M, Kulkarni P. (2012). Lyophilization monophase solution technique for improvement of the solubility and dissolution of piroxicam. Res Pharm Sci 7:13.
   PubMedGoogle Scholar
• Gao S, Sun J, Fu D, et al. (2012). Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-β-cyclodextrin inclusion complex-loaded albumin nanoparticles. Int J Pharm 427:410–6.
   PubMed Web of Science ®Google Scholar
• Gattefosse (2010). Available at: http://www.gattefosse.com/en/applications/?administration-route,oral,solubility-bioavailability-enhancers [online] [last accessed 4 Sept 2016].
   Google Scholar
• Gora S, Mustafa G, Sahni JK, et al. (2016). Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study. Drug Deliv 23:930–40.
   Web of Science ®Google Scholar
• Hauschke D, Steinijans V, Pigeot I. (2007). Bioequivalence studies in drug development: methods and applications. Chichester, West Sussex, England: John Wiley & Sons.
   Google Scholar
• Helmy A, Mohamed AK, Abd-Elbary A. (2012). Effect of Indian complexation on the stability and bioavailability of some non-steroidal anti-inflammatory drugs. Int J Drug Deliv 4:198.
   Google Scholar
• Hosny KM, Khames A, Elhady SSA. (2013). Preparation and evaluation of orodispersible tablets containing hydroxylbutyl-β-cyclodextrin-simvastatin solid dispersion. Trop J Pharm Res 12:469–76.
   Web of Science ®Google Scholar
• Huang Y, Luo X, You X, et al. (2013). The preparation and evaluation of water-soluble SKLB610 nanosuspensions with improved bioavailability. AAPS PharmSciTech 14:1236–43.
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. (2007). Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm 341:26–34.
   PubMed Web of Science ®Google Scholar
• Kamble PR, Shaikh KS, Chaudhari PD. (2014). Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin. Adv Pharm Bull 4:197–204.
   PubMedGoogle Scholar
• Kaparthi S, Babu PS. (2015). Risperidone liquisolid compacts–Formulation and evaluation. Der Pharmacia Sinica 6:9–15.
   Google Scholar
• Karataş A, Yüksel N, Baykara T. (2005). Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. Il Farmaco 60:777–82.
   PubMedGoogle Scholar
• Khadka P, Ro J, Kim H, et al. (2014). Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 9:304–16.
   Google Scholar
• Khames A. (2013). Liquisolid technique: a promising alternative to conventional coating for improvement of drug photostability in solid dosage forms. Exp Opin Drug Deliv 10:1335–43.
   PubMed Web of Science ®Google Scholar
• Khanfar M, Salem MS. (2010). Dissolution enhancement of poorly water soluble drugs by co-precipitation in the presence of additives and stabilizers. Jordan J Pharm Sci 2:32–41.
   Google Scholar
• Khanfar M, Sheikh Salem M, Hawari R. (2013). Formulation factors affecting the release of ezetimibe from different liquisolid compacts. Pharm Development Technol 18:417–27.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Chhabra G, Shivani M. (2012). Development and validation of UV spectrophotometric method for the determination of risperidone in bulk and tablets formulation. Int J Pharm Chem Res 1:1–5.
   Google Scholar
• Laurence DR, Bacharach AL. (1964). Evaluation of drug activities: pharmacometrics. ASPET.
   Google Scholar
• Maruthapillai A, Palanisamy K, Sunkara M. (2015). Preparation and characterization of rilpivirine solid dispersions with the application of enhanced solubility and dissolution rate. Beni-Suef University J Basic Appl Sci 4:71–9.
   Google Scholar
• Nadavadekar P, Koliyote S. (2014). Coprocessed excipients for orally disintegrating dosage form. Int J Pharm Res Rev 3:95–100.
   Google Scholar
• Nair AB, Attimarad M, Al-Dhubiab BE, et al. (2014). Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin. Drug Deliv 21:540–7.
   PubMed Web of Science ®Google Scholar
• Novalbos J, López-Rodríguez R, Román M, et al. (2010). Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers. J Clin Psychopharmacol 30:504–11.
   PubMed Web of Science ®Google Scholar
• Ocaña J, Frutos G, Sánchez P. (2009). Using the similarity factor f2 in practice: a critical revision and suggestions for its standard error estimation. Chemometrics Intelligent Laboratory Syst 99:49–56.
   Web of Science ®Google Scholar
• Pal TK, Ghosh U, Panda M. (2014). Comparative bioequivalence study of different brands of telmisartan tablets marketed in India by dissolution modeling and quality control tests. Int J Pharm Phytopharmacol 3:460–8.
   Google Scholar
• Paradkar A, Bakliwal S. (2008). Biopharmaceutics and pharmacokinetics. 3rd ed. Pune, India: Pragati Books Pvt. Ltd.
   Google Scholar
• Pereira SV, Colombo FB, De Freitas LaP. (2016). Ultrasound influence on the solubility of solid dispersions prepared for a poorly soluble drug. Ultrasonics Sonochem 29:461–9.
   PubMed Web of Science ®Google Scholar
• Rainer MK. (2008). Risperidone long-acting injection: a review of its long term safety and efficacy. Neuropsychiatr Dis Treat 4:919–27.
   PubMedGoogle Scholar
• Rangel-Yagui CO, Pessoa A, Jr Tavares LC. (2005). Micellar solubilization of drugs. J Pharm Pharm Sci 8:147–63.
   PubMed Web of Science ®Google Scholar
• Sahu BP, Das MK. (2014). Nanosuspension for enhancement of oral bioavailability of felodipine. Appl Nanosci 4:189–97.
   Web of Science ®Google Scholar
• Saibi Y, Sato H, Tachiki H. (2012). Developing in vitro–in vivo correlation of risperidone immediate release tablet. AAPS PharmSciTech 13:890–5.
   PubMed Web of Science ®Google Scholar
• Sambasevam KP, Mohamad S, Sarih NM, Ismail NA. (2013). Synthesis and characterization of the inclusion complex of β-cyclodextrin and azomethine. Int J Mol Sci 14:3671–82.
   PubMed Web of Science ®Google Scholar
• Sanka K, Poienti S, Mohd AB, Diwan PV. (2014). Improved oral delivery of clonazepam through liquisolid powder compact formulations: in-vitro and ex-vivo characterization. Powder Technol 256:336–44.
   Web of Science ®Google Scholar
• Savjani KT, Gajjar AK, Savjani JK. (2012). Drug solubility: importance and enhancement techniques. ISRN Pharm 2012: Article ID 195727, 10 pages. doi:10.5402/2012/195727.
   PubMedGoogle Scholar
• Seedher N, Kanojia M. (2008). Micellar solubilization of some poorly soluble antidiabetic drugs: a technical note. Aaps PharmSciTech 9:431–6.
   PubMed Web of Science ®Google Scholar
• Serajuddin AT. (2007). Salt formation to improve drug solubility. Adv Drug Deliv Rev 59:603–16.
   PubMed Web of Science ®Google Scholar
• Sertsou G, Butler J, Hempenstall J, Rades T. (2002). Solvent change co-precipitation with hydroxypropyl methylcellulose phthalate to improve dissolution characteristics of a poorly water‐soluble drug. J Pharm Pharmacol 54:1041–7.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Alanazi FK, Alsarra IA, Haq N. (2014). Solubility of antipsychotic drug risperidone in Transcutol + water co-solvent mixtures at 298.15 to 333.15 K. J Mol Liquids 191:68–72.
   Web of Science ®Google Scholar
• Shanmugam S. (2015). Granulation techniques and technologies: recent progresses. BioImpacts: BI 5:55.
   PubMed Web of Science ®Google Scholar
• Silva A, González-Mira E, García M, et al. (2011). Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf B: Biointerf 86:158–65.
   PubMed Web of Science ®Google Scholar
• Spireas S. (2002). Liquisolid systems and methods of preparing same. U.S. Patent 6,423,339.
   Google Scholar
• Spireas S, Bolton SM. (1999). Liquisolid systems and methods of preparing same. Google Patents.
   Google Scholar
• Strickley RG. (2004). Solubilizing excipients in oral and injectable formulations. Pharm Res 21:201–30.
   PubMed Web of Science ®Google Scholar
• Syed IA, Pavani E. (2012). The liquisolid technique: based drug delivery system. Int J Pharm Sci Drug Res 4:88–96.
   Google Scholar
• Takano R, Furumoto K, Shiraki K, et al. (2008). Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation. Pharm Res 25:2334–44.
   PubMed Web of Science ®Google Scholar
• U.S. Pharmacopeia and National Formulary. (2002). U.S. Pharmacopeia and National Formulary: USP 25-NF 20. Supplement 1. Rockville, MD: United States Pharmacopeial Convention, Incorporated.
   Google Scholar
• Vemula VR, Lagishetty V, Lingala S. (2010). Solubility enhancement techniques. Int J Pharm Sci Rev Res 5:41–51.
   PubMedGoogle Scholar
• Xu WJ, Xie HJ, Cao QR, et al. (2016). Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers. Drug Deliv 23:41–8.
   PubMed Web of Science ®Google Scholar
• Xu W, Cui Y, Ling P, Li LB. (2012). Preparation and evaluation of folate-modified cationic pluronic micelles for poorly soluble anticancer drug. Drug Deliv 19:208–19.
   PubMed Web of Science ®Google Scholar